Mercer Global Advisors Inc Maravai Lifesciences Holdings, Inc. Transaction History

Mercer Global Advisors Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$5.11 - $8.76 $9,238 - $15,838	-1,808 Reduced 8.55%	19,345 $168,000
Q4 2023 Feb 14, 2024	BUY	$4.7 - $9.87 $357 - $750	76 Added 0.36%	21,153 $139,000
Q3 2023 Nov 13, 2023	BUY	$9.14 - $12.85 $60,835 - $85,529	6,656 Added 46.15%	21,077 $211,000
Q2 2023 Aug 14, 2023	BUY	$12.09 - $15.0 $47,682 - $59,160	3,944 Added 37.64%	14,421 $179,000
Q1 2023 May 15, 2023	BUY	$12.99 - $16.48 $136,096 - $172,660	10,477 New	10,477 $146,000

234

140M

223K

19.4K

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $723M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

Stay updated on Mercer Global Advisors Inc with notifications on news.